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ABSTRACT
Homing endonucleases (HEs) can be used to
induce targeted genome modification to reduce the
fitness of pathogen vectors such as the malaria-
transmitting Anopheles gambiae and to correct dele-
terious mutations in genetic diseases. We describe
the creation of an extensive set of HE variants with
novel DNA cleavage specificities using an integrated
experimental and computational approach. Using
computational modeling and an improved selection
strategy, which optimizes specificity in addition to
activity, we engineered an endonuclease to cleave
in a gene associated with Anopheles sterility
and another to cleave near a mutation that causes
pyruvate kinase deficiency. In the course of this work
we observed unanticipated context-dependence
between bases which will need to be mechanistically
understood for reprogramming of specificity to
succeed more generally.
INTRODUCTION
Targeted gene correction requires site-specific DNA
cleavage to initiate cellular programs for DNA break
repair (1). A double-stranded break (DSB) can stimulate
homologous recombination pathways to correct deleteri-
ous genetic mutations or insert a desired DNA sequence at
the site of the break using a template with DNA arms that
match the sequence surrounding the cleavage location.
This process can be used to generate directed modifications
in animal models and shows potential for human gene
therapy (2). A number of nucleases—zinc-finger nucleases
(ZFNs) (3), transcription activator-like effector nucleases
(TALENs) (4), CRISPR nucleases (5,6) and homing endo-
nucleases (HEs, also known as meganucleases) (7–9)—can
make targeted breaks to activate gene conversion. Each
of these reagents differs in its enzymatic properties and
the ease of redesign of specificity.
LAGLIDADG homing endonucleases (LHEs)
(Figure 1a) have several desirable characteristics as gene
therapy reagents (8). These enzymes are likely to cleave at
few loci within a human genome because of their high
specificity recognition (18–22 bp target sites, Figure 1b)
and, because LHEs are typically single-chain proteins
with coupled cleavage and binding activity (10,11), they
have rapid cleavage kinetics (12) and a low potential for
off-target cleavage compared to nucleases with less
concerted activities. Other advantages of these nucleases
include the 3’ overhangs of the resultant DSB, potentially
increasing rates of homologous recombination (13,14),
and their small encoding ORFs without repetitive
elements, desirable for nuclease delivery and maintenance
in a host organism (15). The major disadvantage of these
nucleases is that they are significantly more difficult to
engineer to cleave novel target sites than some of their
counterparts, such as the modular TALE nucleases (16).
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Overcoming this challenge is essential to using HEs in
gene targeting applications.
Both experimental-directed evolution (17–19) and com-
putational methods (20–24) have been developed for
altering protein–DNA interaction specificity. The former
approaches are limited by the number of protein positions
that can be randomized and the need to maintain specificity
while increasing activity on a desired target site; maintain-
ing the naturally high specificity of these nucleases is critical
if they are to be used as gene therapy reagents because
off-target cleavage events can be detrimental (25).
Computational design has the potential to resolve these
issues by identifying a combination of amino acids that
bind the desired target sequence with high affinity as well
as specificity. However, while computational approaches
have been used to design an enzyme cleaving multiple
(three) adjacent base-pair substitutions (26), the success
rate is still low (12,21,26,27), likely because features of
endonuclease binding and catalysis are not yet well under-
stood and therefore cannot be accurately modeled.
In this article, we present a combined experimental and
computational method for reprogramming HE cleavage
specificity. We approached the challenge of altering target
site recognition by breaking it into two parts: first, the iden-
tification of many variants with specificity shifted by a
single base-pair, and second, the utilization of this infor-
mation to engineer nucleases cleaving more divergent
target sites. New variants cleaving single base-pair substi-
tutions were generated with an improved bacterial selection
method (19), described in the first section of our report,
which enables screening for cleavage specificity in
addition to activity. We then engineered endonucleases
cleaving target sites with multiple base-pair substitutions
by integrating information from the single-site cleaving
variants using computation and library selection. We
generated endonucleases cutting full target sites in a gene
for a human disease model and in a gene predicted to play a
role in Anopheles gambiae reproduction (15,28).
MATERIALS AND METHODS
Construction of genes, libraries and target plasmids
The bacterial selection plasmids pENDO-HE and pCcdB
for the original selection strategy were described previ-
ously (19) and were gifts from Barry Stoddard, originally
from David Liu (Harvard University). The pET15-HE
vector used for protein expression, a variant of pET15
that produces an N-terminal his-tag fusion protein using
the NcoI and NotI restriction sites, was a gift from Barry
Stoddard. The pCcdB plasmids containing the I-AniI
LIB4 target sites (29) with single base-pair substitutions
were built by ligating pCcdB vector cut with NheI and
SacII to oligonucleotides (IDT, Integrated DNA
Technologies) that were phosphorylated and annealed to
form a duplex with compatible sticky ends. Two copies of
each site were used for the selections against single base-
pair substitutions. Some of the substrates (single copies of
the site) used for enzyme assays were built the same way
using the pCcdB vector, while others were constructed on
pBluescript by site-directed mutagenesis (12,30). The
tandem target site arrays were bought as minigenes from
IDT and the arrays were inserted into the pCcdB plasmid
with the NheI and SacII restriction sites. The negative
selection vector was built by ligating two copies of wild-
type (WT) I-AniI LIB4 target site into the NheI and SacII
sites on the pENDO-HE vector. Amino acid libraries were
built using assembly PCR (31) with oligonucleotides con-
taining codons with degenerate nucleotides. These
libraries were ligated into the modified pENDO-HE
vector between the NcoI and NotI restriction sites. All
C-terminal I-AniI libraries (starting at the interface
position 150) were built in the context of the activating
M5 mutations (F13Y, I55V, F91I, S92T, S111Y), and all
N-terminal libraries (interface position 18 to position 72)
were built in the context of M4, which is M5 without the
I55V mutation (32) (Figure 1a). N-terminal variants were
overexpressed with I-AniI-M4 mutations and C-terminal
variants were overexpressed with I-AniI-Y2 mutations
(F13Y, S111Y) because I-AniI-M5 expresses poorly (32).
Directed evolution
A bacterial screen for variants of I-AniI that cleave single
and multiple base-pair substitutions was carried out as
previously described (19,33) with the improvements
described in the results section. An electrocompetent
strain of DH12S Escherichia Coli (Invitrogen) was trans-
formed with a pCcdB plasmid. The pCcdB plasmids used
contained either two adjacent copies of the activated LIB4
version (29) of the I-AniI target site with a single base-pair
substitution or it contained a tandem array of 10–20 single
copy target sites from genes of interest that contained
various multiple base-pair substitutions. The number of
cleavable target sites on the pCcdB plasmid is related to
survival levels, and some endonucleases require as many
as four WT sites to achieve near 100% survival (19). The
optimized Y2 and M5 versions of I-AniI were previously
identified by selection against four copies of the WT site
(32), but show reasonable survival against two or even one
(Supplementary Figure S1). A standard procedure for
electrocompetent cell preparation was used to produce
each pCcdB-containing strain.
For Round 1 selections, endonuclease libraries were
ligated into the new negative selection pENDO-HE
vector (containing two copies of the LIB4 WT I-AniI
site), purified and transformed into 20 ml of the appropri-
ate pCcdB-containing cell line. Ligation products were
purified by running over a PCR cleanup column, leaving
the wash buffer on the column for an extended period of
time (5min) to remove salts, and eluting the samples in
10 ml of water, all of which was transformed. Transformed
bacteria were recovered in Terrific Broth (TB) media at
37C for approximately one-half hour. The recovery was
followed by a selection in 2ml of liquid culture, containing
0.02% L-arabinose and 100 mg/ml carbenicillin, for 4 h at
30C. After liquid selection, a volume of the culture was
plated on a minimal media selection plate (100mg/ml car-
benicillin, 1mM IPTG, 0.02% L-arabinose, 1.5% agar,
M9 salt, 1% glycerol, 0.8% tryptone, 0.2% thiamine,
1mM MgSO4, 1mM CaCl2) and on a LB-agar, 100 mg/
ml carbenicillin control plate. If the selection was a Round
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1, the volumes plated were 1 ml on the control plate and
the entire remainder of the selection (spun down and re-
suspended) on the selection plate. Plates are grown for
36 h at 30C. For Round 2 selections, colonies were
picked from the Round 1 selection plate, grown overnight,
combined and miniprepped, and 1 ml of the mixed plasmid
was re-transformed into 20 ml of the same competent cell
line as the Round 1 ligation. The volumes plated on the
Round 2 selection plates depended on the Round 1
survival and size of the starting library, but 0.2–1 ml was
plated on the control plate and typically 0.2–1 ml and
200 ml on selection plates. Colonies on Round 2 selection
plates were either grown up for a third round of selection
or subjected to colony PCR to amplify the endonuclease
ORF off of the pENDO-HE vector and the PCR products
were sequenced.
Protein production
Proteins were expressed and purified as previously
described (34). The genes for each expressed I-AniI
variant were either amplified from clones saved from the
selection process or assembled de novo (31). These genes
were cloned into pET15-HE with NcoI and NotI site,
sequence verified and expressed in BL21 Star cells
(Invitrogen) using autoinduction (35). Either a half- or
full-liter of media was inoculated and grown at 37C for
8–12 h. Expression at 18C continued for 20–24 h, and
then the cells were harvested, often frozen overnight,
and resuspended in 20mM Tris, pH 7.5, 30mM
Imidazole and 1.0M NaCl. The cells were resuspended
with lysozyme and sonicated, and proteins were isolated
from the soluble fraction with nickel affinity chromatog-
raphy and elution with 20mM Tris, pH 7.5, 500mM
Imidazole and 500mM NaCl. Proteins were concentrated
and buffer exchanged into 20mM Tris, pH 7.5, 500mM
NaCl using spin concentrators and stored in 50% (v/v)
glycerol. The purity of the proteins assessed with SDS-
PAGE and the mass was verified by mass spectrometry.
The absorbance at 280 nm, collected with a NanoDrop,
was used to determine the protein concentrations.
Concentrations of proteins that were <90% pure were
estimated from stained SDS-PAGE gels.
In vitro endonuclease cleavage assays
Plasmid substrates were linearized, either with the restric-
tion enzyme ScaI for targets on pBluescript (all sites with
single base-pair substitution) or with XbaI for the pCcdB
targets (multiple base-pair substitutions, full- and half-
sites). Additional substrates, used in the assays shown in
Figures 6a and 4, were generated by amplification of a
1 kb fragment from a pCcdB vector containing the sites.
Experiments measuring kinetics always used the full-
length plasmid substrates to maintain consistency with
previously collected kinetic data (12). The enzyme
reaction buffer was previously optimized for activity and
stability of I-AniI, and contained final concentrations of
170mM KCl, 10mM MgCl2, 20mM Tris, pH 9.0 and
1mM DTT. To collect EC1/2max data, corresponding to
the half-maximal cleavage of the target site, endonuclease
variants was assayed at several enzyme dilutions with
(a)
(b)
Figure 1. Structure and specificity of the I-AniI LAGLIDADG HE.
(a) The I-AniI endonuclease (shown here, pdb code 2qoj) was used in
this study, with the addition of activating mutations—Y2, M4 and M5,
detailed in the methods—identified in previous work (32). Monomeric
LAGLIDADG endonucleases are pseudo-symmetric, with two enzyme
halves binding to the left (– half) and right (+ half) sides of the DNA
target that flank the central four bases where cleavage occurs (arrow).
The N-terminal domain binds to the (–) half-site and the C-terminal
domain binds to the (+) half-site. The linker between the two regions
is shown in red and the termini are marked with pink (N) and orange
(C) spheres. The goal of our work is to alter the target site substrate
preferences of these enzymes in order to direct their cleavage to
genomic sites of interest. Many new variants cleaving single base-pair
substitutions in the I-AniI target are presented in this work, and the
labeling scheme for these variants is presented here. The ‘Selected’
enzymes were identified from fully randomized libraries,
‘Computationally guided’ enzymes were either improved versions of
previous computational designs or selected from libraries containing
computationally identified motif contacts, and the ‘Previously pub-
lished’ enzymes are presented as well to show the full range of currently
targeted positions in the I-AniI interface. (b) Experimentally determined
specificity for the I-AniI endonuclease (Y2), derived from previously
published kinetic data on each single base-pair substitution (12).
Experimental specificity is defined in the Methods section on computa-
tional specificity prediction—a value close to 1.0 indicates that the
enzyme has high specificity and a value of 0.25 indicates that all nu-
cleotides are cleaved equally or that one other nucleotide is significantly
preferred over the target nucleotide.
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100 ng (5 nM) of linearized substrate for 30min at 37C.
For every variant, eight serial 2-fold dilutions, ranging
from 5 to 1500 nM of purified protein, were performed
in 1.25X reaction buffer and then were diluted with sub-
strate to 1X in a 10 ml volume. Reactions were halted with
17 nM EDTA, followed by 60C incubation for 5–
10min. Cleavage products were separated on a 1.2%
agarose TBE gel and stained with ethidium bromide.
The spectral density of the substrate and product bands
was quantified using ImageJ, as previously described.
Fraction cleavage, calculated by dividing the total
density of product and substrate bands by the product
band densities, was plotted versus endonuclease concen-
tration using GraphPad Prism. At least two independent
assays were completed for each cleavage experiment.
The EC1/2max was calculated by fitting the fraction
cleavage to a sigmoid function and using a value of 1.5
for the Hill coefficient, as previously described (34).
Kinetics experiments were completed in the same way as
these EC1/2max experiments, and are previously described
in further detail (12), except that the starting reaction
volume was larger and samples were removed and the
reaction halted at time points ranging from 15 s to
64min. Reaction rates were calculated by plotting
fraction cleavage versus time and the Michaelis–Menten
parameters were calculated from relationship between
reaction rate and enzyme concentration. For variants
cleaving single base-pair substitutions, we defined specifi-
city (36–39) as the following:





Computational modeling for generating motif-biased
libraries
All protocols were implemented within the Rosetta mo-
lecular modeling package (20). They are or will be avail-
able for free academic use through the Rosetta Commons,
and are currently available to institutions participating in
Rosetta Commons (or upon request). The code revision
number used for the calculations in this work is 52 947.
Our strategy for using amino acid sidechain-base inter-
actions frequently observed in the protein databank—
interaction ‘motifs’—was introduced in (33). These
motifs are defined as the spatial arrangement of six
atoms, three on the DNA base and three on the protein
residue interacting with that base. Protein–DNA motif
pairs with high interaction energy, based on Rosetta cal-
culations, were collected from previously published crystal
structures and a library of motif interactions was
generated. The information in these motifs was then
used to bias the results of the computational modeling
and design of libraries for experimental selection. In this
work, amino acid conformations (rotamers) were built at
protein positions in a 6 Å sphere surrounding the target
base-pair and those conformations that were capable of
forming a motif interaction from the motif library were
identified. Starting from the backbone coordinates of the
2qoj protein–DNA complex, potential motif interactions
with each base-pair substitution were identified using the
Rosetta application motif_dna_packer_design. If a strong
motif interaction could form between a particular amino
acid type and the target base-pair, then the amino
acid identity was fixed in the selected library for that
base-pair. The exact tested libraries are available in
Supplementary Tables S1 and S2.
Target site selection for putative mosquito fertility genes
A position-specific scoring matrix (PSSM) matrix was
applied to interrogate the A. gambiae genome and to
produce a list of genes with potentially engineerable I-
AniI target sites within their coding sequence, ranked in
order of engineerability, to produce a subset of 500 genes.
The code for the PSSM program that was used, written in
C++ for rapid analysis of entire organism genomes, is
available on github at the following address:
https://github.com/jashworth-isb/pssm–
From this subset of genes containing potential I-AniI
sites, candidate genes with putative roles in female fertility
were chosen based on either their tissue-specific expression
profile as revealed from microarray data (28) or their
annotated biology. Specifically, genes with high rank-
normalized ovary expression and high tissue restriction
(tau) (28) of this expression were prioritized, as were
genes whose direct ortholog in the model insect
Drosophila melanogaster were known to have at least one
female sterile allele. From a list of genes that were con-
sidered to have suitable biology to warrant targeting by a
re-engineered I-AniI, the genes containing the sites shown
in Table 1 were chosen as targets based on the predicted
ease of engineering an I-AniI variant to cleave the site.
RESULTS
Improving bacterial selection methods for achieving new
cleavage specificities
Bacterial selection can be a powerful tool for reprog-
ramming protein–DNA interactions and screening
Table 1. Target sites were identified in genes associated with
Anopheles sterility and genetic diseases











The WT I-AniI target sequence is shown in all upper-case letters,
whereas substitutions in these target sites are in lower-case.
Substitutions colored blue are tolerated by the WT I-AniI endonuclease
as single changes and are not directly adjacent to a position that is not
tolerated. Substitutions that are not tolerated and are the targets of
interface engineering are colored red. Central four substitutions are
colored green. Sites labeled with the AGAP prefix are in the
A. gambiae genome, the FAH1313 site is in a murine model of
tyrosinemia, and the CPK sites are in a canine model of PK deficiency.
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computationally designed libraries. A previously described
selection system couples survival of bacteria to cleavage of
a plasmid containing both the target site of interest and an
ORF coding for a toxic DNA gyrase poison (CcdB) (19).
Target site cleavage causes degradation of the pCcdB
plasmid, allowing for survival and retrieval of active
variants (Figure 2a). The two drawbacks to this system
are that it can favor non-specific enzymes and is quite
labor-intensive. Non-specific enzymes are generated
because the selective pressure of the system is for
enzyme activity rather than specificity. The selection is
low-throughput both because of high background levels
of survival and because a different pCcdB-containing
strain of bacteria must be prepared for every target site
of interest. Even a background survival as low as 0.1%
translates into significant secondary screening efforts for
library sizes of 105 or greater, as there would be on the
order of 100 background colonies. To overcome these
difficulties, we introduced an additional selective
pressure for specificity that reduces background survival,
and increased system throughput by including several
target sites (>10) in tandem onto a single pCcdB
plasmid, allowing a single bacterial strain to be used to
test multiple targets.
To select for enzyme specificity in addition to activity, a
target DNA sequence (typically the native endonuclease
site) for which cleavage is not desired is placed on the
plasmid expressing the endonuclease protein (pENDO-
HE) so that its cleavage results in loss of the HE ORF
and hence cell death due to CcdB expression. Bacterial
survival is thus linked to cleavage of the desired site on
the toxic pCcdB as well as lack of cleavage of the un-
desired site on the nuclease encoding pENDO-HE
(Figure 2b). As expected, target sites that are cleaved
well in in vitro cleavage assays resulted in low bacterial
survival when included on the pENDO-HE plasmid,
while positions that are cleaved with low efficiency dis-
played high survival (Supplementary Figure S1).
Enzymes with high specificity for their intended target
show high survival in a system with the WT site on
(a)
(b)
Figure 2. Bacterial directed evolution system for selecting endonuclease variants with high specificity. (a) Schematics of the plasmids used in the
bacterial selection system. The pENDO-HE plasmid expresses the endonuclease and contains an HE target for negative selection. The pCcdB plasmid
expresses the CcdB protein, a DNA gyrase poison, which causes bacterial cell death if the target sites on the plasmid are not cleaved by the
endonuclease. Both the modifications to allow for specificity selection and increase system throughput are shown in red. (b) Comparisons of
endonuclease activity with kinetic data from in vitro cleavage assays, survival in the original selection system and survival in the improved
system with the specificity selection component. An extended comparison of survival and in vitro cleavage activity for multiple single base-pair
substitutions in the I-AniI target is available in Supplementary Figure S1.
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pENDO-HE (Figure 2b), indicating that the new specifi-
city selection works as designed. The addition of specifi-
city selection also improved system throughput by
eliminating background survival of low-specificity and
high-activity WT enzymes, thus reducing the screening
efforts necessary to identify variants with successful speci-
ficity switches. Further increasing system throughput,
we alleviated the need for making a pCcdB-containing
bacterial strain for every target site being tested by
putting many divergent target sites, differing by more
than a single base-pair not tolerated by the WT endo-
nuclease, on one pCcdB plasmid (see Supplementary
Methods). The improved system was used to engineer
enzymes for multiple base-pair substitutions and full
target sites in genes of interest.
Generating new HE specificities by integrating
computation and experimental selection
The bacterial selection system with the negative selection
specificity modification was used to generate highly
specific variants of the LAGLIDADG endonuclease
I-AniI that cleave sites with single base-pair substitutions
in the WT target (Supplementary Table S1,
Supplementary Figure S2). Initially, libraries were made
by randomizing several protein residues neighboring base-
pairs for which no successful computational designs were
previously recovered. In addition to generating variants
using randomized libraries, several previously described
I-AniI computational designs (12) with high specificity
but low overall activity were improved using the
modified selection system; the residues predicted to be
most critical to the switch in specificity were fixed and
the surrounding residues varied. Many of these selected
endonucleases were expressed and purified, and their spe-
cificity was measured by in vitro cleavage assays with each
of the four single base-pair substitutions at the targeted
position (Figure 3a). Enzymes obtained from these experi-
ments with high specificities often contain residues pre-
dicted to form strong hydrogen bonds with the target
base-pair (Supplementary Figure S3).
To favor redesigns with such strong sidechain-base
hydrogen bonds, similar to the improved computational
designs, we used a computational procedure to search for
canonical protein–DNA interactions, which we refer to as
‘motifs’, extracted from a large set of protein–DNA struc-
tures (33,40). The motifs are collected from high-reso-
lution crystal structures based on calculated interaction
energies between sidechain and base atoms. To incorpor-
ate these motif interactions in interface designs, sidechain
conformations (rotamers) for all 20 amino acids are
generated for protein positions near a substituted base
and the rotamers are scored based on whether they can
form one of the interactions seen in the motif library. We
showed previously that inclusion of the rotamers making
motif interactions improved results for computational
benchmarks (33), but the methods were not evaluated
with experimental testing.
For each substitution in the I-AniI target site, libraries
were generated where an amino acid type computationally
predicted to make a motif interaction was kept fixed and
surrounding residues were varied. These libraries were built
both for single base-pair substitutions for which variants
had already been identified with the fully randomized
approach, and also for positions were no variant had yet
been identified. Endonuclease variants with new speci-
ficities were selected from these motif-derived libraries,
including some for target site substitutions for which
active nuclease variants were not previously recovered.
The likelihood of identifying an active and specific
variant is increased in these computational motif libraries
because all members contain a predicted high-quality
contact and because the library size is reduced (41). For
example, libraries with full randomization of positions 18,
33, 59 and 68 yielded no high-surviving variants for
position4C, but a library with a motif lysine fixed at pos-
ition 33 (and randomization of the other three positions, as
well as position 31) showed 46% survival after two rounds
of selection (Supplementary Table S1).
The combination of the selected variants described and
those previously published (12,34) allow targeting of a
large number of single base-pair substitutions in the I-
AniI target site (Figure 3b, Supplementary Figure S2
and Supplementary Table S1). There are 60 possible
single base-pair substitutions in the 20 bp I-AniI site
(20 3). In this work, we attempted to generate variants
cleaving 39 of the 60 substitutions, excluding those under
the two edge loops of the endonuclease (–10,+9 and+10,
relatively non-specific regions of the interface (12)) and
those in the central four bases that are not directly con-
tacted by amino acids. Both of these areas are challenging
to engineer and model-loops are flexible and the sequence
preference in the central four is not currently understood
(12,34,42,43). In total, we characterized 64 I-AniI variants
cleaving 26 distinct single base-pair substitutions (12,34)
out of the 39 attempted, 51 of which were generated in this
work (Figure 3c, Supplementary Table S1; we obtained
libraries cleaving four additional sites but did not charac-
terize individual clones). Libraries were attempted and no
reasonably active variants were identified for 9A, 9T,
6A, 4A, +6A, +6T and all three substitutions at
position 7. This extensive dataset of single base-pair spe-
cificity switches is a valuable benchmark that can be used
for evaluating and guiding the improvement of computa-
tional design methods. We describe preliminary results
comparing computational predictions and experimental
data in the Supplementary Material (Supplementary
Figures S4, S5 and S6, Supplementary Discussion A).
Combining single base-pair variants to cleave target
half-sites
We chose Anopheles reproduction (15) and several genetic
disorders as model challenges for genome engineering with
endonucleases. To identify near-native I-AniI target sites
in the relevant genes, we used a PSSM (26), provided in
the Supplementary Methods, that incorporates informa-
tion about substitutions that can be cleaved by the WT
endonuclease (Figure 1b) and those that are cleaved by the
newly selected variants (Figure 3c). Including specificity
data for the large number of new I-AniI variants
evolved in this work was critical to identifying target
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sites requiring minimal enzyme engineering. Potential
target sites for I-AniI engineering were found in the
genes involved in the diseases pyruvate kinase (PK) defi-
ciency (44) and tyrosinemia (45), as well as several genes
putatively associated with Anopheles reproduction
(Table 1) (28). Targets from genetic diseases in which
the desired outcome is to correct mutations using homolo-
gous recombination were chosen to be very close to the
site of mutation in order to ensure efficient gene conver-
sion. We chose a site in the PK gene—CPK2 (canine PK
site 2)—occurring only 53 bases away from the mutation




Figure 3. Combining directed evolution with computational design to successfully select for variants cleaving targets with single base-pair substi-
tutions in the I-AniI target site. (a) Representative data from cleavage assays with each of the four single base-pair substitutions at the targeted
position for variants exhibiting high or low specificity. Data for the other I-AniI variants are available in Supplementary Figure S2. (b) Activity and
specificity of I-AniI endonuclease variants that cleave single base-pair substitutions (Supplementary Figure S2, Supplementary Table S1). Each point
in the graphs is an enzyme variant and is colored to reflect the substituted nucleotide in the cleaved DNA target, both those toward which the
enzyme was evolved or the preferred substitution, in the case where an alternate non-WT nucleotide was preferred with over twice the specificity to
the target. These three plots include the majority of the 64 variants discussed in this work, with the exceptions of two published enzymes without
EC1/2max data available and three selected enzymes with EC1/2max-values of over 500 nM for all base-pairs at the target position. (c) Summary of the
single base-pair substitutions in the I-AniI target site that can be cleaved with the engineered variants. Of the 39 substitutions for which selection was
attempted—substitutions at 10, +9, +10, and the central four were skipped—variants cleaving 26 substitutions were expressed and characterized
(Supplementary Table S1). Blue, sites cleaved by engineered variants; purple, sites for which high-surviving variants were identified but the endo-
nucleases were not expressed; and red, sites for which cleaving variants were not obtained.
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Redesign to cleave target sites of interest will almost
always involve changing specificity at multiple base-
pairs. In early experiments, we found that mutations
from two single base-pair variants could be successfully
combined without further selection, even when they were
separated by only a single base-pair (Supplementary
Figure S7). However, this approach is unlikely to work
for base substitutions directly neighboring one another
as mutating amino acids to alter the specificity at one
position could result in changes in specificity at the neigh-
boring bases. Also, if multiple variants have been
identified for a particular single base-pair substitution,
utilizing only one such variant does not take advantage
of the sequences of others that may prove more compat-
ible with other desired target site changes. To address
these challenges, we combined information from the
already identified I-AniI single base-pair variants with
computational modeling, assessing the compatibility of
the amino acid mutations present in the single-site
cleaving variants and identifying new motif residues for
adjacent substitutions, and performed further in vivo
selection. We broke down the target sites into groups of
substitutions that were close together or into half-sites,
building separate libraries for groups of substitutions in
the two half-sites.
We used this approach to engineer variants cleaving the
half-sites of a target site identified in the CPK2 gene
(Figure 4). For the (–) half of the CPK2 site (Figure 4a),
a library was generated incorporating mutations from two
single base-pair variants cleaving 6C and 4T with ran-
domization allowed in the region in between and sur-
rounding the two positions (Supplementary Table S2).
The mutations identified by screening of this library
using the bacterial selection system resulted in a variant
with increased specificity at position-5 (compared to the
WT I-AniI that cleaves all 4 nt equally (Figure 1b))
(Figure 4b). The specificity at 6 and 4 was similar to
that of the starting single base-pair variants
(Supplementary Figure S2, Supplementary Table S1),
and the WT specificity was maintained at positions 2
and +1 (Figure 1b). Modeling the sequence changes of
amino acids arising from single base-pair variants
ensured their compatibility and identified neighboring
protein positions that were varied in the subsequent selec-
tion libraries. The (+) half of the CPK2 site contains
multiple substitutions, including two adjacent substitu-
tions, +4G and +5G, and a third, +7G, separated from
the+4G/+5G base-pair pocket by only a single position.
The close proximity of these changes made it impossible to
directly combine already identified variants cleaving single
base-pair substitutions. Therefore, candidate motifs com-
patible with the group of substitutions were identified
computationally and incorporated into a library with sur-
rounding randomization, which was selected against a
target with the +4G/+5G substitutions alone. From this
selection, variants with the S166K motif incorporated
(Figure 4c) were found to have high survival
(Supplementary Table S2). Sequences of active endonucle-
ases from these S166K selections were used to generate
further libraries that incorporated randomization over
the+7G nt. The evolved variant chosen from this selection
cleaved +7G well, whereas the WT enzyme did not
(Figure 1b). While this endonuclease also tolerated other
substitutions at +7, further optimization of protein pos-
itions near+9 and+10 resulted in greatly increased spe-
cificity at position +10 compared to the WT enzyme
(Figure 1b) and high activity on the CPK2 (+) half-site
(Figure 4d).
While this step-wise approach proved successful for en-
gineering variants cleaving both halves of the CPK2 site,
we had less success for a target in the FAH1313 gene
(Table 1). We were able to generate a highly active and
specific variant for two substitutions, +5C and +6C, by
screening a library containing two in silico predicted
motifs, Y192K and Y192R (Figure 4e and f,
Supplementary Table S2). However, when these mutations
were combined with those from several variants available
that cleave+3C well (Figure 3, Supplementary Figure S2,
Supplementary Table S1; positions 170, 194 and 200),
none of the libraries tested yielded endonucleases with
high specificity and activity for the entire (+) half-site.
This result suggests that there may be unanticipated
coupling between regions of the endonuclease interface.
Characterizing unanticipated specificity shifts in
endonuclease catalysis
A particularly striking case of site coupling was observed
in the course of targeting a second site in the canine PK
gene, CPK1 (Table 1). This site contains the substitutions
+1G, +3C and +5G, as well as additional substitutions
farther away from the central four bases. Both+1G and
+5G are cleaved as well as the WT nucleotides by I-AniI,
but the+3C substitution is cleaved very poorly (Figure 5a)
(12). We succeeded in generating several enzyme variants
with high specificity and activity for +3C using the bac-
terial selection. The most specific of these, +3C_S1,
contains the mutation A170E, predicted to form a direct
contact with the+3 cytosine nucleotide (Figure 5b). This
enzyme cleaves a target containing both the+1G and+3C
substitutions more rapidly (higher kcat*) than the +3C
target alone. Surprisingly, however, the triply substituted
site+1G/+3C/+5G is cleaved very slowly (low kcat*). To
determine whether this unexpected coupling is specific to
the evolved variant, we measured the cleavage rates of the
WT I-AniI endonuclease (Y2 version) on the same set of
target substrates (+1G/+3C, +3C/+5G and +1G/+3C/
+5G). The overall pattern of kcat*-values was very
similar between the two enzymes (Figure 5c), suggesting
there are substrate preferences that are largely independ-
ent of the protein sequence, further complicating the com-
putational design process. Indirect readout and target
preferences inherent to the DNA substrate have been
previously reported for this family of endonucleases
in the central four region (43), and the current results
show that this context-dependence extends beyond the
central four.
Targeting full cleavage sites in mosquito and disease genes
We also identified several target sites associated with
Anopheles sterility (Table 1). These targets contain fewer
position changes than the CPK2 target, and a number
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of these changes can be cleaved individually by the new
variants generated in this work (Figure 3c). Furthermore,
through selection against the AGAP003225 (+) half-site
combining the+7C_S1 variant with sequence information
from variants targeting the+4A base-pair (Supplementary
Figure S2, Supplementary Table S1), we generated a
variant cleaving a site with two single base-pair substitu-
tions present in both the AGAP004671 and AGAP003225
(+) half-sites. This variant cleaves the AGAP003225 (+)
half-site with an in vitro EC1/2max of 22 nM and shows
activity in human cell assays (Supplementary Figure S9)
(42,46).
The chosen Anopheles target sites also contain add-
itional substitutions that are partially tolerated by the
WT endonuclease (Figure 1b) and were not selected for,
such as those in the central four and on the edges of the
target site. It was unclear whether variants would exhibit
context-dependent specificity changes, as observed for
enzymes tested with the CPK1 and FAH1313 (+) half-




Figure 4. Combining computation and selection to cleave multiple base-pair substitutions with high specificity. Libraries screened to generate
variants, exact mutations tested and the data shown are detailed in Supplementary Table S2 and Supplementary Figure S8. The WT amino acids
in the region of interest are shown in gray in the upper portion of panels (a, c and e), and residues predicted to be important for activity and
specificity (data in panels (b, d and f)), are shown in the lower portion. Protein backbone positions shown as magenta are supporting positions that
were varied in the selection process, but did not yield the dominant contacts. Any substrates not shown in panels (b, d and f) are missing because the
process used to generate the target sites utilized a batch method for large numbers of substrates mixed together and these missing constructs were not
successfully derived from the group. Bars with dashes indicate that no cleavage was visible at the highest tested enzyme concentration. (a) The (–)
half of the CPK2 site contains multiple base-pair substitutions, including 6C and 4T. An enzyme was engineered to target a site with both
changes by combining amino acid mutations from variants previously engineered for each single base-pair substitution. Mutations targeting 6C
(from 6C_C1) are shown in green and mutations for 4T (from 4C_C1) are shown in blue. (b) Cleavage of the CPK (–) half-site with the
CPK2_N enzyme (exact mutations in Supplementary Table S2) and targets containing the indicated base substitution, measured by in vitro cleavage
with 1700 nM of the CPK2_N enzyme. (c) The (+) half of the CPK2 site contains the adjacent substitutions +4G and +5G, as well as the
substitutions +7G, +9C and+10C. The +4G/+5G pocket was targeted before the entire half-site by selecting enzymes from motif-biased libraries,
and a library containing the S166K (green) motif produced successful variants that provided a starting place for further selections against the entire
(+) half-site. Positions in yellow are contacts that were identified from selections against the CPK2 (+) half-site. For example, the mutation L156K is
predicted to hydrogen bond with the two guanines on the reverse strand of the+9C/+10C double base-pair pocket and the D168S mutation caused a
significant increase in survival over a D168A-containing variant (Supplementary Table S2). (d) Activity data for two enzyme variants, CPK2_C1
(variant 2) and CPK2_C3 (variant 1), selected from libraries based on the positions shown in panel (c) tested in vitro against the CPK2 (+) half-site
and targets with the indicated single base-pair substitution. The two variants differ from each other by two mutations, D168S and T204A, in
CPK2_C3 (variant 1) that increase activity over CPK2_C1 (variant 2). (e) The FAH1313 (+) half-site contains the adjacent substitutions +5C and
+6C. A library incorporating a motif residue at position 192 was targeted to this double base-pair pocket. Both a lysine and an arginine residue were
identified by the computational methods, and surviving variants included both mutations. (f) Activity data for the enzyme FAH1313_Ccc (Table S2),
selected to cleave+5C/+6C and incorporating the Y192K motif residue (panel (e)). Data were collected for the full FAH1313 site and all single base-
pair substitutions.
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targets. Thus, we tested five variants evolved to cleave
different single base-pair substitutions present in
Anopheles target genes (Table 1) and compared their
cleavage activity against both the target with the singly
substituted site and the Anopheles target half-sites contain-
ing the substitution as well as additional substitutions
tolerated by the WT enzyme (Figure 6a). The majority
of the variants cleaved both the singly substituted target
and the half-sites with similar efficiency, and in one case
(AGAP009607 (+)) was even more active against the
latter. These results indicate that site context-dependence
is not a complication for all target site combinations.
The half-site activity tests also indicated that the
AGAP003225 and CPK2 targets were the most promising
candidates for full-site cleavage, due to the strong
activities obtained toward their (+) half-sites. We
attempted to generate endonucleases to cleave these
full-sites by combining the tested mutations for each
half-site with no further engineering. Both the CPK2
and AGAP003225 sites were successfully cleaved
(Figure 6a and b). The AGAP003225 site was cleaved
relatively efficiently, with an EC1/2max of 131 nM, compar-
able to many of the variants that successfully cleave single
base-pair substitutions in the in vivo bacterial selection
system. The variant targeting the CPK2 site cleaved its
cognate target much less well; kinetics studies revealed
that this enzyme has a kcat* of over 5min
1, similar to
the I-AniI endonuclease scaffold (Y2 variant) with a rate
of 9.4min1 (12), but (Figure 6c) a KM* over 3 mM,
(a)
(b)
(c) Concentration dependence of CPK2
cleavage kinetics
Figure 6. Cleaving full- and half-sites in genes associated with
Anopheles sterility and genetic diseases. (a) Activity of variants
selected against single base-pair substitutions (SV, single-site variant),
half (– or+) (HV, half-site variant) and full-sites (FV, full-site variant)
tested against the indicated target with in vitro cleavage assays. The
color scheme for base-pair substitutions is the same as Table 1.
Single variants are from the set of previously tested variants introduced
in Figure 3, and sequences of all tested variants are in Supplementary
Table S2. The dashed bars for the CPK2 HV w/ the (–) half-site
indicate that an accurate EC1/2max-value could not be collected
and this estimate was derived from data in Figure 5. Stars mark the
two full variants shown to cleave their respective full-target sites.
(b) Gel images showing specific cleavage of full target CPK2 and
AGAP003225 sites by engineered enzymes, as well as lack of cleavage
by the WT I-AniI scaffold (Y2) at even higher protein concentrations.
Specificity for individual positions in the single base-pair changes in the
AGAP003225 target and multiple base-pair changes in the CPK2
target are shown in, respectively, Figure 4 and Supplementary Figure
S2. (c) Kinetic data for the endonuclease engineered to cleave the full
CPK2 target. The rate of target site cleavage by the endonuclease
engineered to cleave the full CPK2 target continues to increase above




Figure 5. Combining (+) side target substitutions results in cleavage
specificity switches that are independent of protein sequence. (a)
Kinetic data (kcat*) for the I-AniI enzyme with three targets containing
single base-pair substitutions found in the CPK1 site. The I-AniI
enzyme cleaves two of three substitutions,+1G and+5G, as efficiently
as the WT target and does not cleave the third, +3C. (b) Variants
selected to cleave the +3C position contained the A170E mutation
over the cytosine. This amino acid is predicted to form a motif inter-
action with the cytosine nucleotide. (c) Kinetic parameters for the
+3C_S1 (A170E, D194K, K200A and Y2 mutations) and I-AniI-Y2
enzymes against targets with different combinations of +1G and +5G
with the +3C substitution.
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compared to 81 nM for I-AniI. The high kcat* indicates
that the catalytic center was successfully reconstituted
when the two redesigned halves were combined, but
further optimization is necessary to increase the overall
affinity of the enzyme for the CPK2 site.
DISCUSSION
We have engineered an extensive set of new I-AniI HE
variants with distinct cleavage specificities (Figure 3). To
generate these enzymes, we modified a bacterial selection
system to select for higher specificity endonuclease
variants while simultaneously improving system through-
put (Figure 2). Guided by the observation that high spe-
cificity generally involved an amino acid sidechain that
makes hydrogen bonds with the target base, we used a
computational method for identifying such ‘motif’ inter-
actions and used them to bias library design
(Supplementary Figure S3, Figure 4). The combination
of a highly efficient selection system with input from com-
putational models in library design is an advance over
previous approaches using random selection or computa-
tion alone (9,21,27,47,48).
These new methods, as well as the collection of data on
protein–DNA interactions and catalysis, are applicable to
the reprogramming of specificity for other nuclease
families. For example, the CRISPR/Cas9 family of nucle-
ases is becoming a popular catalyst for genome engineer-
ing (6,49–51), and the methods presented in this work
could be used to increase the specificity of Cas9 (52–54)
or expand the targeting potential of this class of enzymes,
currently limited by the PAM sequence motif at the end of
the target site (GG for Cas9) (5,55,56).
While our successes cleaving the CPK2 site and
AGAP003225 site are promising, kinetic analysis of the
CPK2 enzyme revealed that its binding affinity is subopti-
mal (Figure 6) and will require further improvements to
become a useful gene therapy reagent. Determination of
the crystal structure of the protein–DNA complex would
greatly facilitate further rational design approaches to
increasing affinity. Alternatively, the enzyme could be
further optimized through selection, using either random
mutagenesis across the entire protein sequence (32) or
homolog-based sequence libraries (32,34,48). The large
number of natural endonuclease homologs is a reservoir
of potentially useful sequence information that can
be used to improve specific properties of these enzymes;
we discuss our progress using this information to improve
I-AniI affinity in the Supplementary Material
(Supplementary Figures S10 and S11, Supplementary
Discussion B). Determining how to improve suboptimal
enzymes would help to identify features of endonuclease
function that are currently missing from our models.
We have identified several challenges that will need to
be resolved for robust rational redesign of endonuclease
specificity, notably unexpected context dependencies
between base-pair substitutions (Figures 4, 5 and 6).
While previous attempts to engineer the specificity of
this nuclease family have also recognized this challenge
(26,43,47), our kinetic analyses of the CPK1 target
shows that indirect readout mechanisms extend far
beyond the central four region of the substrate.
Identifying the origins in the non-additivity in the effects
of base substitutions on endonuclease cleavage, whether
from the interactions between the N- and C-terminal
domains (57,58), DNA bending at the center of the
target site (43,59,60), or other causes is a current
research challenge.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online,
including [61–69].
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